Vistin Pharma ASA

OB:VISTN Stock Report

Market Cap: NOK 1.1b

Vistin Pharma Balance Sheet Health

Financial Health criteria checks 5/6

Vistin Pharma has a total shareholder equity of NOK310.7M and total debt of NOK5.6M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are NOK387.9M and NOK77.2M respectively. Vistin Pharma's EBIT is NOK82.7M making its interest coverage ratio -20.1. It has cash and short-term investments of NOK5.6M.

Key information

1.8%

Debt to equity ratio

NOK 5.64m

Debt

Interest coverage ratio-20.1x
CashNOK 5.63m
EquityNOK 310.74m
Total liabilitiesNOK 77.21m
Total assetsNOK 387.94m

Recent financial health updates

Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

Feb 23
Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Feb 20
We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Recent updates

Here's Why Vistin Pharma (OB:VISTN) Has Caught The Eye Of Investors

Sep 18
Here's Why Vistin Pharma (OB:VISTN) Has Caught The Eye Of Investors

Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

Feb 23
Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

A Look At The Fair Value Of Vistin Pharma ASA (OB:VISTN)

Sep 09
A Look At The Fair Value Of Vistin Pharma ASA (OB:VISTN)

Robust Earnings May Not Tell The Whole Story For Vistin Pharma (OB:VISTN)

Aug 25
Robust Earnings May Not Tell The Whole Story For Vistin Pharma (OB:VISTN)

Investors In Vistin Pharma ASA (OB:VISTN) Should Consider This, First

Mar 15
Investors In Vistin Pharma ASA (OB:VISTN) Should Consider This, First

We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Feb 20
We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Could The Vistin Pharma ASA (OB:VISTN) Ownership Structure Tell Us Something Useful?

Jan 29
Could The Vistin Pharma ASA (OB:VISTN) Ownership Structure Tell Us Something Useful?

The Vistin Pharma (OB:VISTN) Share Price Is Up 119% And Shareholders Are Boasting About It

Jan 08
The Vistin Pharma (OB:VISTN) Share Price Is Up 119% And Shareholders Are Boasting About It

Have Insiders Been Selling Vistin Pharma ASA (OB:VISTN) Shares?

Dec 16
Have Insiders Been Selling Vistin Pharma ASA (OB:VISTN) Shares?

Is Vistin Pharma ASA (OB:VISTIN) At Risk Of Cutting Its Dividend?

Nov 26
Is Vistin Pharma ASA (OB:VISTIN) At Risk Of Cutting Its Dividend?

Financial Position Analysis

Short Term Liabilities: VISTN's short term assets (NOK143.8M) exceed its short term liabilities (NOK67.4M).

Long Term Liabilities: VISTN's short term assets (NOK143.8M) exceed its long term liabilities (NOK9.8M).

Debt to Equity History and Analysis

Debt Level: VISTN's net debt to equity ratio (0%) is considered satisfactory.

Reducing Debt: VISTN's debt to equity ratio has increased from 0% to 1.8% over the past 5 years.

Debt Coverage: VISTN's debt is well covered by operating cash flow (1770%).

Interest Coverage: VISTN earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y